Physicist's Fast for Peace Stirs His Colleagues

BOSTON—Two hundred and eight days after he began a fast to protest the nuclear arms race, astrophysicist Charles Hyder stood in the rain across the street from the White House to announce his decision to run for president. He admitted his "candidacy" is an attempt to draw attention to his campaign to get the United States and Soviet Union to begin to dismantle their nuclear arsenals. But his willingness to die for his beliefs has posed a dilemma for many scientists active in the disarmame

Written bySeth Shulman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

He admitted his "candidacy" is an attempt to draw attention to his campaign to get the United States and Soviet Union to begin to dismantle their nuclear arsenals. But his willingness to die for his beliefs has posed a dilemma for many scientists active in the disarmament movement who are nonetheless uncomfortable with his tactics.

A group of several dozen scientists at Harvard and MIT has been meeting regularly since Hyder began his fast September 23, monitoring his actions and lending a hand. Twenty-four of them, including physicist Sheldon Glashow, held a one-day fast last fall in support of Hyder's commitment, if not his tactics.

One of the organizers of these Boston-based efforts is Robert Noyes, a professor of astronomy at the Smithsonian Astrophysical Observatory who has known Hyder for 20 years. Noyes, who tried to convince Hyder that he would help his cause more by remaining alive, now "has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies